Outlook Therapeutics, Inc. — Key Metrics
2 years of history · ending 2025-09-30 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-2
Book Value Per Share
$-1
Free Cash Flow Per Share
$-1
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity
118.6%
Return on Assets
-263.4%
Return on Invested Capital
100.7%
Debt to Equity
—
Current Ratio
0.38
Quick Ratio
0.31
Asset Turnover
0.06
Days Sales Outstanding
384.99
Days Payables Outstanding
2742.86
Days Inventory On Hand
898.39
Cash Conversion Cycle
-1459.48
R&D / Revenue
1922.9%
SBC / Revenue
629.5%
Capex / Revenue
—
Working Capital
$-28M
Net Current Asset Value
$-33M
Invested Capital
$-32M
OCF / Net Income
0.83
FCF / Net Income
0.83
Accruals Ratio (Sloan)
-57.0%
Net Debt
$-8M
Net Debt / EBITDA
0.12
Interest Coverage
-22.71
Cash Coverage
-21.79
Capex Coverage
—
Tangible Common Equity
$-32M
TCE / Total Assets
-173.2%
NOPAT
$-53M
Cash ROIC
98.5%
WC / Revenue
-2011.0%
Capex / D&A
—
Reinvestment Rate
0.2%
Asset Growth vs Revenue Growth
-180.3%
Stock Price (FY-end)
$1
Market Cap
$37M
P/S Ratio
26.09
P/B Ratio
—
P/TB Ratio
—
Enterprise Value
$29M
EV / Sales
20.38
FCF Yield
-140.5%
Shareholder Yield
-24.1%
R&D Yield
73.7%
Capex Yield
—
Shares Variation (YoY)
87.6%
Beta (5Y)
1.17
Cost of Equity
10.4%
Cost of Debt (after tax)
—
52W High
$7
52W Low
$1
Trailing Return 1Y
-81.3%
Trailing Return 5Y
-91.8%
F-Score (Piotroski)
2.00
Z-Score (Altman)
-58.86
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.